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Abstract
Background: Development of the neuromuscular junction (NMJ) is initiated by the formation of postsynaptic specializations
in the central zones of muscles, followed by the arrival of motor nerve terminals opposite the postsynaptic regions. The
post- and presynaptic components are then stabilized and modified to form mature synapses. Roles of ADAM (A Disintegrin
And Metalloprotease) family proteins in the formation of the NMJ have not been reported previously.
Principal Findings: We report here that Meltrin b, ADAM19, participates in the formation of the NMJ. The zone of
acetylcholine receptor a mRNA distribution was broader and excess sprouting of motor nerve terminals was more
prominent in meltrin b–deficient than in wild-type embryonic diaphragms. A microarray analysis revealed that the
preferential distribution of ephrin-A5 mRNA in the synaptic region of muscles was aberrant in the meltrin b–deficient
muscles. Excess sprouting of motor nerve terminals was also found in ephrin-A5 knockout mice, which lead us to investigate
a possible link between Meltrin b and ephrin-A5-Eph signaling in the development of the NMJ. Meltrin b and EphA4
interacted with each other in developing motor neurons, and both of these proteins localized in the NMJ. Coexpression of
Meltrin b and EphA4 strongly blocked vesicular internalization of ephrin-A5–EphA4 complexes without requiring the
protease activity of Meltrin b, suggesting a regulatory role of Meltrin b in ephrin-A5-Eph signaling.
Conclusion: Meltrin b plays a regulatory role in formation of the NMJ. The endocytosis of ephrin-Eph complexes is required
for efficient contact-dependent repulsion between ephrin and Eph. We propose that Meltrin b stabilizes the interaction
between ephrin-A5 and EphA4 by regulating endocytosis of the ephrinA5-EphA complex negatively, which would
contribute to the fine-tuning of the NMJ during development.
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Introduction
A neuromuscular junction (NMJ) is the synapse between an axon
terminal of a motor neuron on the presynaptic side and a specialized
region of a muscle fiber on the postsynaptic side. Formation of the
NMJ during development is a multistep process[1–3] . In the initial
phase of NMJ formation, nicotinic acetylcholine receptors (AChRs)
cluster with other postsynaptic proteins in the central regions of the
myofibers after myogenesis independently of innervations by motor
neurons; this process is called ‘‘prepatterning’’ [4–6]. Some proteins
expressed in the muscle, MuSK (a muscle-specific receptor tyrosine
kinase), LRP4, and Dok-7, are essential for this process [7–9]. The
axons of motor neurons are guided by chemoattractants and
chemorepellents to elongate toward target muscles so that the axon
terminals can contact the prepatterned postsynaptic regions. The
pre- and postsynaptic regions then differentiate and are stabilized
and modified by the elimination of redundant synapses to form
structurally and functionally mature NMJs. However, precisely how
these processes occur remains an important unanswered question.
The ADAM (a disintegrin and metalloprotease) family proteins
play critical roles in morphogenesis, fertilization, and diseases. Some
ADAM proteins contain an active metalloprotease domain, and
ADAM proteases modulate the ectodomain shedding of various
membrane proteins, such as membrane-anchored growth factors,
receptors, and adhesion molecules. For example, tumor necrosis
factor-a converting enzyme (TACE/ADAM17) is essential for the
phorbol ester–stimulated shedding of the ectodomains of various
membrane-anchored proteins [10], and Kuzbanian/ADAM10 is
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3322involved in the ectodomain shedding of multiple substrates,
including ephrin, Notch ligands, and cadherins [11–15].
Meltrin b, an ADAM protein that contains an active
metalloprotease domain, is strongly expressed in the heart and
peripheral nervous system during development [16,17]. Meltrin b
mediates the ectodomain shedding of neuregulin b1, a membrane-
anchored ErbB ligand, in cultured cells [18–20].
Although the protease functions of ADAM proteins have been
studied most intensively, these proteins contain other domains [21]
such as the disintegrin domain, and it is important to investigate
the functions that ADAM proteins may possess in addition to their
protease activity. We previously generated meltrin b
2/2 mice to
further study the properties of Meltrin b. Using these mice, we and
another group showed that Meltrin b is involved in the heart
development [22–24]. In the C57BL/6 background, meltrin b
2/2
mice are born, but die immediately after birth. Neonatal death is
often caused by respiratory failure, including defective regulation
of the contractions of respiratory muscles, such as the diaphragm
and intercostal muscles. This finding, combined with the
expression of Meltrin b in the peripheral nervous system [17],
led us to further investigate the roles of this gene in the
development of the NMJ.
In this study, we found that Meltrin b plays a regulatory role in
the formation of NMJs. The zone of acetylcholine receptor a
mRNA distribution was broader and excess sprouting of motor
nerve terminals was more prominent in meltrin b–deficient than in
wild-type embryonic diaphragms. A microarray analysis revealed
aberrant distribution of ephrin-A5 in addition to acetylcholine
receptor a transcripts in meltrin b
2/2 mice. Excess sprouting of
axon terminals were also found in ephrin-A5
2/2 mice, which lead
us to examine whether Meltrin b regulates ephrin-A5-Eph
signaling in the formation of the NMJ. Meltrin b interacted with
EphA4 in motor neurons during development, and the expression
of Meltrin b in EphA4-expressing cells blocked the vesicular
internalization of ephrin-A5 bound to EphA4, independently of
the Meltrin b metalloprotease function. Previous studies indicated
the requirement of endocytosis in efficient contact-dependent
repulsion induced by ephrin-Eph signaling. From these results and
previous findings, we propose that Meltrin b negatively regulates
ephrin-A5-EphA vesicular internalization, which could be one of
mechanisms to stabilize the developing NMJ.
Results
Meltrin b is expressed at the NMJ and involved in its
formation
To examine the role of Meltrin b in the development of the NMJ,
we first investigated the expression of Meltrin b at the NMJ in
muscles (Fig. 1A–C). Anti-Meltrin b antibody recognizes the C-
terminus of Meltrin b, and show little affinity to other proteins in
meltrin b
2/2 mice ([22], also see Figure S1S). Acetylcholine receptors
(AChRs) were visualized with Alexa-594–a-bungarotoxin (BTX). In
the adult, Meltrin b was expressed at NMJs (Fig. 1C, arrowheads).
During development, expression of Meltrin b gradually clustered at
the NMJ during the late stage of embryogenesis (Figure S1).
To investigate whether Meltrin b is involved in the formation of
the NMJ, we performed whole-mount immunostaining of wild-
type and meltrin b
2/2 diaphragms to examine the distribution of
presynaptic axon terminals and postsynaptic AChR clustering
(Fig. 1D–I). In wild-type embryos at embryonic day (E) 18.5,
AChR clusters were confined to the central endplate zone, and
axon terminals of motor neurons detected with synaptophysin
were apposed to the AChR clusters (Fig. 1D–F). In contrast, in
meltrin b
2/2 embryos AChR clusters were more broadly
distributed (Fig. 1H, I, also compare the bars in E and H), and
excess sprouting of the axon terminals was observed prominently
(Fig. 1G, I, arrowheads). Consistent with these data, the zone of
AChRa mRNA distribution was broader in meltrin b
2/2 than in
wild-type diaphragms at E18.5 (Fig. 1J, K; see the bars).
Furthermore, distribution of AChR clusters remained sparse in
diaphragms of meltrin b
2/2 newborns, and the average size of
AChR clusters was smaller in meltrin b
2/2 than in wild-type
muscles (Fig. 1L). The primary phrenic nerve trunk projected onto
the muscles normally (data not shown). Together, these results
indicate that Meltrin b is expressed at the NMJ and contributes to
fine-tuning of the formation and/or maintenance of the NMJ.
Gene expression pattern in synapse-rich and synapse-
free sites of wild-type and meltrin b
2/2 muscles
We hypothesized that muscles of meltrin b
2/2 mice would
exhibit aberrant gene expression patterns related to their defects in
NMJ formation. We microdissected AChR-positive ‘‘synaptic
regions’’ (Fig. 2A, B) and AChR-negative ‘‘extrasynaptic regions’’
(Fig. 2A, C) from wild-type and meltrin b
2/2 diaphragms, as
described previously [25]. We performed a microarray analysis,
and all of the genes expressed in the synaptic and extrasynaptic
regions in wild-type and meltrin b
2/2 muscles were analyzed by
GeneChip Operating Software (GCOS; Affymetrix). The genes
were categorized into 3 groups: genes expressed more highly in
synaptic regions than in extrasynaptic regions of wild-type muscle
(Fig. 2D, green), genes expressed in synaptic regions more highly
in wild-type than in meltrin b
2/2 muscle (Fig. 2D, red), and genes
whose expression patterns differed between wild-type and meltrin
b
2/2 muscles (Fig. 2D, blue). The third class of genes included
genes expressed differentially in the synaptic and extrasynaptic
regions only in wild-type or meltrin b
2/2 muscles. Among 110
genes that fulfilled all the criteria (Table S1), secreted or
membrane-bound proteins were selected. In addition, we sought
to identify candidates that could act as a retrograde signal from the
muscles to motor terminals. All of the criteria mentioned above
were on the premise that the hybridization conditions for the array
data from the 4 probes prepared from S (transcripts localized in
the synaptic region) and E (transcripts localized in the extra-
synaptic region) from wild type and meltrin b
2/2 muscles,
respectively, were absolutely the same. However, we could not
expect such ideally equal conditions of the hybridization although
each array data was evaluated with several internal controls.
Therefore, we next assessed several candidate genes with RT-
PCR. As a result, the RT-PCR analyses revealed that ephrin-A5,i n
addition to AChR alpha, was exclusively localized in the synaptic
region in wild type but not in meltrin b
2/2 muscle among several
candidates we selected. Inconsistent with the array data,
expression of ephrin-A5 was even higher in meltrin b
2/2 muscle
than in wild type muscle. However, we were interested in this gene
because of its roles in morphogenesis and synaptogenesis. A result
representative of the RT-PCR analyses is shown in Fig. 2E.
Ephrin-A5 is localized at the NMJ and participates in
formation of the NMJ
Previously, Feng et al. showed that motor axons formed
topographic maps on muscles and that ephrin-A5 and –A2 were
involved in that topographic mapping [26] . They showed that
ephrin-A5 was expressed in developing muscles. We investigated
the localization of ephrin-A5 by using immunohistochemistry of
E18.5 intercostal muscles (Fig. 3A–C). Ephrin-A5 protein was
localized at the NMJ (Fig. 3A, C, arrowheads), a distribution that
emerged gradually during the late stage of embryogenesis (Figure
ADAM19 in Formation of NMJs
PLoS ONE | www.plosone.org 2 October 2008 | Volume 3 | Issue 10 | e3322ADAM19 in Formation of NMJs
PLoS ONE | www.plosone.org 3 October 2008 | Volume 3 | Issue 10 | e3322S1). Then, we performed whole-mount immunostaining of dia-
phragms from wild-type and ephrin-A5 knockout (ephrin-A5
2/2)
mice (Fig. 3D–I). In wild-type diaphragms, AChR clusters were
tightly expressed in the central endplate zone opposite the nerve
terminals (Fig. 3D–F). In contrast, in ephrin-A5
2/2 mice the axon
terminals branched excessively (Fig. 3G–I, arrowheads). Thus,
ephrin-A5 also plays a role in the precise positioning of axon
terminals apposed to the postsynapses as Meltrin b does.
Figure 2. Comparison of gene expression profiles in synaptic and extrasynaptic regions of wild-type and meltrin b
2/2 diaphragms at
E18.5. (A) Schematic diagram of synapse-rich (synaptic) (B, marked by a square) and synapse-free (extrasynaptic) (C, marked by a square) regions in
the diaphragm. The primary phrenic nerve trunks and AChR clusters are indicated by green lines and red dots, respectively. (B and C) Wild-type and
meltrin b
2/2 diaphragms at E18.5 were stained with Alexa-594–conjugated BTX (red) and DAPI (blue), and their synaptic (B) and extrasynaptic (C)
regions were dissected for a microarray analysis. Bar: 100 mm. (D) All the genes expressed in the synaptic or extrasynaptic regions from wild-type and
meltrin b
2/2 mice were classified into 3 groups that were analyzed with GCOS software. Green: genes expressed more highly in synaptic regions than
in extrasynaptic regions of wild-type muscle, Red: genes expressed in synaptic regions more highly in wild-type than in meltrin b
2/2 muscle, Blue:
genes expressed in extrasynaptic region more highly or expressed similarly in synaptic and extrasynaptic regions in meltrin b
2/2 muscles. (E) The
preferential expression of the AChR a subunit and ephrin-A5 genes in synaptic regions is aberrant in meltrin b
2/2 diaphragm muscles at E18.5.
Transcripts of several genes in synaptic (S) and extrasynaptic (E) regions were analyzed by RT-PCR. Compared with transcripts of the G3PDH gene as a
control, those of AChR a subunit, MuSK, and ephrin-A5 were expressed differentially in synaptic and extrasynaptic regions in wild-type diaphragms,
but the AChR a subunit and ephrin-A5 genes were expressed similarly in synaptic and extrasynaptic regions in meltrin b
2/2 diaphragms.
doi:10.1371/journal.pone.0003322.g002
Figure 1. Meltrin b is expressed at the NMJ and participates in the formation of the NMJ. (A–C) Adult tibialis anterior (T.A.) muscles were
stained with an anti-Meltrin b antibody (A) and Alexa-594–conjugated a-bungarotoxin (BTX) (B). Meltrin b was expressed at NMJs (C, arrowheads).
Meltrin b was also expressed in a part of muscle fibers. Bar: 10 mm. (D–I) The diaphragms of wild-type (D–F) and meltrin b
2/2 (G–I) mice at E18.5 were
stained with an anti-synaptophysin antibody (D and G) to label axon terminals and with BTX (E and H) to label acetylcholine receptors (AChRs). AChR
clusters were distributed more broadly (H and I, also compare the bars in E and H) and the nerve terminals sprouted excessively (G and I, arrowheads)
in the meltrin b
2/2 muscle compared with in the wild-type muscle (F). Bar: 100 mm. (J and K) In situ hybridization with probes for AChR a-subunit
mRNA in E18.5 diaphragms of wild-type (J) and meltrin b
2/2 (K) mice. The central zone expressing the AChR a-subunit mRNA is broader in meltrin b
2/
2 (K) than in the wild-type diaphragm (J) (compare the bars in J and K). (L) Neonatal (P0) diaphragms were stained with BTX. AChR clusters were
distributed more broadly in meltrin b
2/2 than in wild-type diaphragms (left panel). The average size of the individual AChR clusters was smaller in
meltrin b
2/2 muscles relative to that in wild-type muscles (right panel). Bar: 100 mm.
doi:10.1371/journal.pone.0003322.g001
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vivo
Ephrin-A5 is a glycosylphosphatidylinositol-anchored protein
expressed in muscles and is a ligand for a group of membrane-
bound receptor tyrosine kinases, the Ephs. Motor neurons express
EphA4 receptors [27–30], and EphA4 is localized at the NMJ [31].
Islet 1/2–positive motor neurons of E12.5 spinal cords expressed
Meltrin b as well as EphA4 (Fig. 4A–D). We asked whether Meltrin
b interacts with EphA4 in motor neurons to regulate ephrin–Eph
signaling. As shown in Fig. 4E–G, immunoprecipitation analyses
were performed. When myc-tagged Meltrin b and HA-tagged
EphA4 were co-expressed in HEK293T cells, these two proteins
interacted with each other (Fig. 4E). When HA-tagged Meltrin b
lacking its ectodomain was co-expressed with EphA4, the mutant
Meltrin b did not precipitate EphA4; in contrast, EphA4 did co-
precipitate with Meltrin b lacking the cytoplasmic domain (Fig. 4F).
This suggested that Meltrin b, through its ectodomain, interacts with
EphA4. We tested whether Meltrin b interacts with EphA4 in
developing neural cells. We dissected spinal cords and dorsal root
ganglia (DRG) from embryos at E13.5 and lysed them with Triton-
X100 lysis buffer. Proteins were immunoprecipitated with the anti-
EphA4 antibody and immunoblotted with the anti-Meltrin b
antibody. Meltrin b co-immunoprecipitated with EphA4 (Fig. 4G,
open arrow), suggesting that Meltrin b interacts with EphA4 in
neural cells during development.
Meltrin b does not affect the EphA4 expression pattern
or ephrin–Eph association, but decreases the accessibility
of antibodies against EphA4 C-terminus
Meltrin b reaches lipid rafts to cleave the neuregulin-b1
extracellular region [19] , and is expressed mainly in the Golgi
apparatus and the intracellular vesicles around it [20]. The
Figure 3. Ephrin-A5 is expressed at the NMJ during development and participates in the formation of the NMJ. (A–C) E18.5 intercostal
muscles were stained with ephrin-A5 (A) and BTX (B). The BTX-positive postsynaptic apparatus colocalized with ephrin-A5 (C, arrowheads). (D–I)
Diaphragm muscles from wild-type (D–F) and ephrin-A5
2/2 (G–I) mouse embryos at E18.5 were stained with anti-neurofilament (NF) 145 and anti-
synaptophysin (SYN) antibodies (D and G) and BTX (E and H). Excess sprouting of the nerve terminals was prominent in the ephrin-A5
2/2 muscle (I,
arrowheads. Compare with the wild-type muscle in F). Arrow: sensory neuron from the lateral part of the diaphragm. Bar: 100 mm.
doi:10.1371/journal.pone.0003322.g003
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cells led us to investigate intracellular localization of Meltrin b in
the existence of EphA4. When Meltrin b was expressed together
with EphA4, some of the Meltrin b proteins were translocated to
the cell surface (Figure S2). Then, we examined whether Meltrin b
affects the membrane localization of EphA4 on the cellular
membrane. We compared the amount of EphA4 expressed on the
cell surface; this was estimated by cell surface biotinylation, in
NIH3T3 cells transformed with EphA4-HA, with or without the
exogenous expression of Meltrin b (Fig. 5A). Meltrin b expression
did not affect the expression of EphA4 on the cell surface (Fig. 5A,
arrowhead). Next, we investigated the distribution of EphA4 in
lipid raft and non-raft fractions (Fig. 5B). EphA4-HA was
expressed together with wild-type Meltrin b (Meltrin b WT);
Meltrin b EQ, which contains a point mutation in the active site of
its metalloprotease domain; or the empty plasmid as a control, and
total cell lysates were prepared from each transfectant with Triton-
X100 lysis buffer. We divided the cellular lysates into two
Figure 4. Meltrin b interacts with EphA4 in the peripheral nervous system. (A–D) Sequential sections of the spinal cord at E12.5 were
double-stained with antibodies against EphA4 (A) and islet 1/2 (A, inbox) or against Meltrin b (B) and Islet 1/2 (C). EphA4 and Meltrin b proteins were
expressed in Islet 1/2–positive motor neurons (indicated by arrows). Dotted lines show dorsal root ganglia (DRG). Bar: 50 mm. (E)
Immunoprecipitation was performed with HEK293T cells transfected with HA-tagged EphA4 and myc-tagged Meltrin b. EphA4 coimmunopreci-
pitated with Meltrin b (anti-myc, left panel), and full-length Meltrin b coimmunoprecipitated with EphA4 (anti-HA, right panel). (F)
Immunoprecipitation was performed with NIH3T3 cells expressing. EphA4 and meltrin b domain-deletion mutants tagged with HA. The ectodomain
of Meltrin b, but not its cytoplasmic domain, is required for interactions with EphA4 (open arrow). (G) Coimmunoprecipitation was performed with
lysates prepared from E13.5 embryonic spinal cords and DRG using the anti-EphA4 antibody used in (F). Endogenous Meltrin b (open arrow) was
coimmunoprecipitated with EphA4 (closed arrow) in vivo. The bands for IgG and non-specific bands (asterisks) in the lane for control mouse IgG were
higher than those in the lane for EphA4 because the concentration of control IgG used in this experiment was higher in this experiment, further
excluding that the band for EphA4 is one of non-specific bands.
doi:10.1371/journal.pone.0003322.g004
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PLoS ONE | www.plosone.org 6 October 2008 | Volume 3 | Issue 10 | e3322Figure 5. Meltrin b does not affect the expression of EphA4 on the cell surface nor the initial association between ephrin-A5 and
EphA4, but decreases accessibility of antibodies that recognize the EphA4 C-terminus. (A) EphA4-HA transformant cells were transfected
with Meltrin b expression plasmids (meltrin b) or with control vectors, and biotinylated proteins on the cell surface were precipitated with streptavidin
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resistant insoluble fraction, and analyzed them with anti-HA
antibodies. The distribution pattern of EphA4 in the soluble and
insoluble fractions was not altered by the expression of Meltrin b
WT or the EQ mutant, regardless of stimulation with ephrin-A5-
Fc, a chimeric protein of a soluble form of ephrin A5 and a human
Fc fragment. However, the amount of EphA4 protein in the
soluble fraction that was precipitated with an anti-HA antibody
(clone HA-7) was reduced significantly when Meltrin b WT or the
EQ mutant was expressed in the cells (Fig. 5B, bottom). Similar
results were obtained with an anti-EphA4 antibody that recognizes
the SAM domain in the cytoplasmic region of EphA4 (Fig. 5C).
These results suggest that the C-terminus, especially SAM domain,
of EphA4 becomes less accessible to these antibodies when Eph4A
interacts with Meltrin b, independent of ephrin-A5 stimulation,
and that the interaction of these two proteins does not require the
protease activity of Meltrin b.
To investigate whether Meltrin b regulates the initial association
of ephrin and Eph on the cell surface, we performed a cell
adhesion assay as described previously [32]. The EphA4
transformants were seeded on plastic dishes that had been coated
with human Fc fragments or ephrin-A5-Fc, and the number of the
cells adhering to the dishes was counted (Fig. 5D). The number of
adhesive cells was not altered by the expression of Meltrin b. Thus,
expression of Meltrin b does not affect the expression pattern of
EphA4 proteins in microdomains of cells or the initial association
of EphA4 with ephrin-A5, although the EphA4 C-terminus
becomes less accessible when Eph4A interacts with Meltrin b.
Meltrin b regulates endocytosis of the ephrin–Eph
complex
The SAM domain in the C-terminus of EphA4 is required for the
endocytosis of ephrin–Eph complexes [33]. The interaction between
EphA4 and Meltrin b led us to examine whether Meltrin b regulates
the internalization of the ephrin-A5–EphA4 complex. Because
ephrin-induced endocytosis of EphA4 is known to promote the
retraction of Eph-expressing axon terminals, regulators of this
endocytosis would play important roles in contact-dependent
retraction during axon guidance and synaptogenesis. [34]
To test whether Meltrin b regulates the internalization of the
ephrin-A5-EphA4 complex, we added ephrin-A5-Fc or human Fc
fragment (as a negative control) to EphA4-HA transformants, and
analyzed the complex with anti-Fc fragment antibodies by using a
confocal microscope (Fig. 6). When the cells were incubated at
12uC—a process that inhibits endocytosis—ephrin-A5-Fc bound
to the cell surface uniformly whether or not the cells were
exogenously expressing Meltrin b (Fig. 6A–D), suggesting that
Meltrin b does not affect the affinity between ephrin-A5-Fc and
EphA4. When cells not transfected with Meltrin b were incubated
at 37uC—a process that allows endocytotic activity—ephrin-A5-Fc
was internalized into the cells after it interacted with EphA4, and
numerous intracellular particles containing ephrin-Eph complexes
were observed (Fig. 6E, arrowheads). In contrast, the internaliza-
tion of the ephrin-Eph complexes was inhibited in cells transfected
with Meltrin b, although ephrin-A5-Fc bound to the cell surface
(Fig. 6E, asterisk). Human Fc fragments did not bind to or was not
endocytosed significantly in this assay (Fig. 6I–L), indicating that
internalization of the complexes was dependent on the association
of ephrin-A5 with EphA4. As quantitative results, the number of
cells without endosomes containing the ephrin-Eph complexes
(that is, in which endocytosis was inhibited) was approximately 7
times higher for cells expressing Meltrin b than for control cells
(Fig. 6Q). Meltrin b EQ mutant proteins also inhibited the
endocytotic activity as much as Meltrin b WT did (Fig. 6M–P, Q),
indicating that the protease activity of Meltrin b is not needed for
this regulation of endocytosis.
Discussion
Meltrin b is a metalloprotease-containing member of the ADAM
family of proteins that is expressed in the developing heart and
peripheral nervous system (PNS) [16,17]. Wepreviously showed that
Meltrin b played a role in the endocardial cushion development. In
this study, we extended the analyses of meltrin b
2/2 mice in the
developmentofPNSandexploredmolecularmechanismsforit.Our
study revealed a novel role of Meltrin b inthe formation of the NMJ,
and suggested a link between Meltrin b and ephrin-Eph signaling.
Based on these data and previous reports, we discuss possible
mechanismsthroughwhichMeltrinbcontributestotheformationof
NMJs together with ephrin-A5-EphA.
Role of Meltrin b in the development of the NMJ
Muscles develop specialized postsynaptic apparatuses before
motor neurons reach them [4,6]. These prepatterned postsynaptic
structures are stabilized and modified by secreted factors, such as
Agrin and ACh, that emanate from motor neurons[35,36]. In
meltrin b
2/2 mice, AChRa mRNA was distributed in a broader
zone in the muscles and excess sprouting of nerve terminals was
evident. Moreover, preferential expression of the AChR a and
ephrin-A5 genes in the synaptic region of muscles was disrupted in
meltrin b
2/2 mice, whereas the expression pattern of the MuSK
gene, a key player for the prepatterning of the NMJ, was not
affected in these mice. These phenotypes suggest that Meltrin b
does not participate in the prepatterning of the NMJ but mediates
the stabilization of the NMJ through the fine-tuning of terminal
axon branching and/or the transcriptional confinement of some
post-synaptic genes. Consistent with this idea, Meltrin b gradually
beads. The proteins were separated by SDS-PAGE, and EphA4 was detected with an anti-HA antibody (HA-7). Caveolin 2 was used as an internal
control. (B) NIH3T3 cells were transfected with EphA4-HA expression plasmids and the various plasmids listed at the top of the lanes and stimulated
with ephrin-A5-Fc fusion proteins as indicated. The cell lysates were divided into a Triton-X100–solubilized fraction (soluble fraction) and Triton-
X100–resistant raft microdomains (insoluble fraction). After SDS-PAGE separation, EphA4 was detected with HA-7. EphA4 proteins in the soluble
fractions were also immunoprecipitated with HA-7 (the bottom panel) and detected with HA-7 after SDS-PAGE. The amount of EphA4 precipitated
was reduced dramatically when the Meltrin b WT or EQ mutant was coexpressed with EphA4, regardless of stimulation with ephrin-A5. (C) (Upper
Panel) NIH3T3 cells were transfected with EphA4-HA expression plasmids and the various plasmids listed at the top of the lanes and stimulated with
ephrin-A5-Fc fusion proteins as indicated. EphA4 proteins in the soluble fractions (whole cell lysate) were immunoblotted with anti-HA antibody (HA-
7) or immunoprecipitated with an anti-EphA4 antibody and detected with HA-7 after SDS-PAGE. Immunoprecipitation of EphA4 with anti-EphA4 was
inefficient when the meltrin b WT or EQ mutant were coexpressed, regardless of the stimulation with ephrin-A5-Fc. (Lower Panel) An anti-EphA4
antibody from Zymed recognizes the SAM domain in the EphA4-C terminus. NIH3T3 cells were transfected with plasmids that express EphA4-HA or
SAM domain–deleted EphA4-HA, and expressed proteins were detected either with HA-7 or with the anti-EphA4 antibody after SDS-PAGE of the cell
lysates. (D) EphA4 transformants transfected with meltrin b or a control vector were seeded onto plastic dishes coated with a human Fc fragment or
ephrin-A5-Fc. The binding activity of EphA4-expressing cells (detected with DAPI) on ephrin-A5-coated plates was not changed by coexpression of
Meltrin b.
doi:10.1371/journal.pone.0003322.g005
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PLoS ONE | www.plosone.org 8 October 2008 | Volume 3 | Issue 10 | e3322Figure 6. Meltrin b regulates vesicular internalization of the ephrin-A5–EphA4 complexes. (A–L) Ephrin-A5-Fc fusion proteins bound to
EphA4-HA transformants equally regardless of Meltrin b expression at a temperature that inhibits endocytosis (12uC; A–D). In contrast, when the cells
were put at a temperature that promotes endocytosis (37uC), Meltrin b substantially inhibited endocytosis of ephrin–Eph complexes (E–H,
arrowheads: intracellular vesicles containing ephrin-Eph complexes). Control human Fc fragments do not promote endocytosis (I–L). Asterisk: Meltrin
b positive cells. Blue signals in panels C, G, and K are DAPI staining of nuclei. Bar: 10 mm. (M–P) The same experiments were performed for Meltrin b
EQ mutant–expressing cells. EQ mutant proteins also inhibit internalization of ephrin–Eph complexes. (Q) The number of the cells that did not have
intracellular vesicles containing ephrin–Eph complexes was counted. The number of cells without endosomes containing ephrin–Eph complexes was
approximately 7 times or 5 times higher in the Meltrin b WT–positive cells or in the Meltrin b EQ mutant–positive cells respectively than in the control
cells (P,0.01, Student’s t-test).
doi:10.1371/journal.pone.0003322.g006
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the establishment of prepatterning in muscles and initial axon
pathfinding although Meltrin b is expressed in the ventral horn of
the spinal cord already at E12.5.
Role of ephrin-A5 in NMJ Formation
Both Eph receptor tyrosine kinases and ephrins, high-affinity
ligands of Ephs, are membrane proteins. Ephrin–Eph signals
function as topographical guidance cues for neurons [26,29,37]
and synaptogenesis and plasticity of synapses in the central
nervous system [38]. Ephrin-A5 is expressed in the developing
muscles [26] and our study revealed that ephrin-A5 proteins were
concentrated at the NMJ (Fig. 3). Other ephrin-As and EphAs,
including ephrin-A2, EphA4, and EphA7, also localize at the NMJ
in adult or postnatal muscles [31]. The localized expression of
these ephrins and Ephs at the NMJ suggests that they also function
at the interface between motor neurons and muscles during late
stages of development and/or in adult for the formation or
maintenance of the NMJ.
Previous studies showed that Ephrin-A5 is a rostrocaudal
positioning cue for the projection of some motor neurons [26] and
a guidance cue for another group of motor neurons innervating
the muscles of the dorsal limb [28,30]. We asked whether ephrin-A5
was also involved in the fine- tuning of motor axon terminals
during development. In ephrin-A5
2/2 embryos, axon arbors failed
to be stabilized at the postsynaptic sites and excess sprouting of the
motor terminals was prominent at E18.5 in ephrin-A5
2/2 mice.
This phenotype was similar to, but more pronounced than, that of
meltrin b
2/2 mice. These results indicate that ephrin-A5 is
required for the axon terminals to contact with postsynaptic
apparatuses properly. Ephrin-A5
2/2 mice survive to adulthood.
The NMJ of their muscles after birth would be also worth studying
in detail because it is possible that signs of abnormality in the NMJ
of these mice have been unnoticed. Alternatively, because
structurally similar ephrins are expressed in muscles, they might
compensate the phenotype after birth.
In contrast to the molecular mechanisms of prepatterning of the
NMJ postsynaptic regions, the factors produced by muscles to
differentiate presynaptic specializations have been poorly under-
stood. The interaction of ephrins with Ephs leads to bidirectional
signaling events [39,40], and ephrin–Eph interactions can induce
attractive or adhesive responses in addition to repulsive effects
[40–42]. Whereas the forward signaling from ephrin-A5 to EphA4
causes cytoskeletal rearrangements in some conditions [39,40], the
reverse signal from EphA to ephrin-A5 upregulates the expression
of integrin-b1 [43] to modify cell morphology. Integrin-b1i n
muscles is essential for the formation of stable NMJs [44],
supporting a molecular link between ephrin-A5 and integrin-b1i n
NMJ formation. In Xenopus, ephrin-A5 acts as an attractive signal
to neurons in cooperation with laminin [45]. At the NMJ, a
specific laminin, laminin-b2 [46,47], may cooperate with ephrin-
A5 to attract and stabilize motor terminals. Thus, the adhesive
ephrin–Eph interaction at the NMJ could be a noticeable
mechanism through which contact-dependent bidirectional sig-
naling contributes to development of the pre- and postsynaptic
specializations.
A regulatory role for Meltrin b in ephrin-A5–EphA
signaling
The molecular interaction between Meltrin b and EphA4, the
similarity of the phenotypes of ephrin-A5
2/2 and meltrin b
2/2 mice
at the NMJ, and the aberrant ephrin-A5 mRNA expression in
meltrin b
2/2 mice suggest a relationship between Meltrin b and
ephrin-A5–EphA signaling. Although Meltrin b was not found at
the cell surface without coexpressing with EphA4, some Meltrin b
molecules were translocated to the cell surface when Meltrin b was
co-expressed with EphA4 (Figure S2). Because Meltrin b is not
usually found at the cell surface, we interpret the result as
indicating that the molecular interaction with EphA4 likely
promoted the translocation of Meltrin b to the cell surface.
The most important question was whether Meltrin b regulates the
ephrin-A5–EphA4interaction. An ephrin–Eph interaction delivers a
contact-triggered repulsive signal to the ephrin- and Eph-expressing
cell [11,39]. Mechanisms to convert the signal from contact to
repulsion include cleavage of the ephrin. Ephrin-A2 is cleaved by
ADAM10 in cis upon binding to EphA receptor, and a cleavage-
inhibiting mutation in ephrin-A2 delays axon withdrawal [11]. In
contrast,Janeset al.showed thatADAM10 cleavesephrin-A5onthe
membranes of opposing cells (in trans; [12]). Either result of these
experiments with cultured cells can explain contact-triggered
repulsion between ephrin- and Eph-expressing cells. Another
mechanism is endocytosis. Ephrins or Ephs on opposing cells are
endocytosed into the cells expressing Ephs or ephrin, respectively,
without ectodomain shedding, a process called trans-endocytosis
[34,48–50]. With some evidences, it is also suggested that
endocytosis is a critical step for turning the interaction of ephrins
and Ephs from contact into repulsion efficiently [34].
In contrast to ADAM10, Meltrin b did not cleave ephrin-A5
even when ephrin-A5–expressing cells were mixed with EphA4-
expressing cells (data not shown). Instead, the expression of
Meltrin b in EphA4-expressing cells interfered with the endocy-
tosis of ephrin-A5–EphA4 complexes (Fig. 6). This interference
might diminish the ability of ephrin- and Eph-expressing cells to
repel with each other. Alternatively, cell-cell adhesion would
overcome the repulsion when EphA4 interactes with Meltrin b.
HowdoesMeltrinbregulate the endocytosis of ephrin-A5–EphA4
complexes? Endocytosis is triggered by Vav family GEFs,which bind
to phosphorylated Ephs and are themselves phosphorylated by other
kinases, possibly of the Src family [51,52]. This results in the
activation of Rac1 GTPase and the endocytosis of ephrin–Eph
complexes [34]. In the current study, when EphA4 interacted with
Meltrin b, EphA4 became less accessible to an antibody against its
SAM domain significantly. We speculate that the association of
EphA4 with Meltrin b may alter the accessibility of endocytosis
regulators to EphA4 or change their association and may prevent
Vav family GEFs from activating ephrin-triggered endocytosis.
On the basis of our findings and previous reports, we present a
working hypothesis of how Meltrin b and ephrin-A5–EphA
signaling cooperate to stabilize the association of the pre- and
postsynaptic apparatuses of the NMJ (Fig. 7). In short, Meltrin b
associated with EphA4 would convert a state of an axon terminal
from a mobile to a static one through modulating the ephrinA5-
EphA4 signaling at the NMJ by interfering with the internalization
of the ephrin-Eph complexes there. This conversion might
contribute to formation of the stabilized NMJ. The sustained
expression of EphA4-Meltrin b at the presynapses would cause
localized expression of ephrin-A5 at the postsynapses, which would
increase the stability of the ephrin-A5-EphA4 interaction.
In summary, this study revealed that Meltrin b plays a role in
the fine tuning of the NMJ during development. Although we
discussed a non-proteolytic role of Meltrin b in the regulation of
ephrin-A5-EphA4 signaling here, functional significance of
Meltrin b as a protease is not excluded in the NMJ formation.
Further studies are necessary to determine whether Meltrin b
presented together with EphA4 on the cell surface also functions as
a protease to cleave substrates, which contribute to the formation
of the NMJ including the confinement of AChR mRNA in the
central endplate zone.
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Meltrin b, many questions remain to be solved: the molecular
mechanisms by which Meltrin b blocks the ephrin-dependent
endocytosis and the mechanisms that localize the Meltrin b–
EphA4 complex in axon terminals apposed to the NMJ. Meltrin b
and EphA4 are not only expressed in neurons but also in
developing muscles (this study and [31]), and ephrin-A5 could be
also expressed in terminal Schwann cells. Cell type-specific
ablation of Meltrin b and ephrin-A5 would help understanding
more precise mechanisms of the NMJ stabilization which these
molecules mediate. It is noteworthy that the expression of ephrins,
Ephs, and Meltrin b in the NMJ is sustained in adult mice,
implying that these molecules are also important in the
maintenance of the NMJ.
Materials and Methods
Generation of meltrin b
2/2 and ephrin-A5
2/2 mice
All procedures with experimental animals were approved by the
Institutional Animal Care Research Advisory Committee at Kyoto
University.C57BL/6meltrinb
2/2mice, in which the active site of the
metalloprotease domain was deleted, were generated previously [22],
and ephrin-A5
2/2 mice were generated as described previously [37].
Antibodies
The following antibodies were used: anti-NF145 (polyclonal;
Chemicon), anti-synaptophysin (polyclonal; Zymed), anti-hemag-
glutinin (HA clone HA-7; Sigma), anti-EphA4 (polyclonal: Santa
Cruz Biotechnology Inc.; clone 4C8H5: Zymed), anti-Meltrin b
(developed by our lab as described previously [18]), anti–islet 1/2
(monoclonal; Developmental Studies Hybridoma Bank), anti-
ephrin-A5 (polyclonal; R&D Systems), anti-b-actin (clone AC-74;
Sigma), anti-caveolin 2 (clone 65; BD Transduction Laboratories),
and anti-human Fc fragment (polyclonal; Jackson ImmunoRe-
search).
Plasmids
The following expression plasmids or control plasmids were
used: pCMV-SPORT 6-ephA4 (Invitrogen), pcDNA3.1-ephA4-HA
(the cytoplasmic end of ephA4 was replaced with a HA tag in the
pcDAN3.1 expression plasmid), pcDNA3.1-ephA4DSAM-HA (the
SAM domain of ephA4 was deleted followed by its endogenous
PDZ-binding sequence), pBIE-meltrin b Dectodomain-HA (the
meltrin b ectodomain was replaced by HA in the pBIE expression
plasmid, [18]), pBIE-meltrin b Dcytoplasmic domain-HA (the
meltrin b cytoplasmic domain was replaced by HA in the pBIE
expression plasmid), pBOS, pBOS-meltrin b wild-type (WT), and
the pBOS-meltrin b EQ mutant (mutation in the metalloprotease
active site to delete metalloprotease activity).
Immunohistochemistry for sections and whole-mount
diaphragms
T.A. muscles and intercostal muscles were dissected from wild-
type adults and E18.5 embryos, respectively, and frozen immedi-
ately. Sections were cut at 10 mm and fixed with ice-cold acetone for
10 minutes.Theywereused forimmunohistochemistrywith an anti-
Meltrin b and anti-ephrin-A5 antibodies. The signal was amplified
with the TSA biotin system (PerkinElmer). For immunofluorescent
stainingoftheembryonicspinalcords,E12.5embryosweredissected
and fixed with 4% PFA. After 3 washes in PBS, the solution was
replaced with 30% sucrose in PBS. The embryos were sectioned at
14 mm, and immunofluorescence was performed as described
previously [30]. For the analyses of the NMJ, the heads were
removed from E18.5 embryos or postnatal day (P) 0 newborns and
the bodies were fixed in 4% paraformaldehyde (PFA) overnight at
4uC, washed twice with phosphate buffered saline (PBS), and whole
mount immunostaining were performed. Alexa-594–conjugated
BTX (Molecular Probes) was used to label AChRs.
To assess the distribution of the size of AChR clusters in P0
diaphragms, Z-stack confocal images were captured on a Leica
Figure 7. Hypothetic model of how Meltrin b and ephrin-A5–EphA4 signaling stabilize the NMJ. When axon terminals touch the ephrin-
A5-expressing postsynaptic region, EphA4 associated with Meltrin b is localized preferentially at the axon terminal opposite the postsynaptic cluster
on the muscle fiber; Meltrin b interferes with the internalization of the ephrin-A5–EphA4 complexes so that the axon terminal and muscle could avoid
receiving a repulsive signal at the NMJ, and many molecules, such as agrin, MuSK and adhesion proteins, cooperate in stabilization of the NMJ. In the
absence of Meltrin b, axon terminals of motor neurons cannot be stabilized because impaired suppression of endocytosis would result in a failure to
block the ephrin-A5–EphA4 repulsive signal. As a result, the motor terminals remain mobile at the NMJ, and the reverse signal from EphA4 to ephrin-
A5 is unstable, leading to the diffuse distribution of ephrin-A5 and AChR transcripts in muscles. (see also text).
doi:10.1371/journal.pone.0003322.g007
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software was used to divide clusters into 11 classes according to
their pixel size.
Microarray analysis
The BTX-positive synapse-rich (synaptic) and synapse-free
(extrasynaptic) regions of the diaphragms from E18.5 embryos
were obtained as described previously [25]. Each region was taken
from 3 wild-type and 3 meltrin b
2/2 mouse embryos. Biotinylated
RNA probes were synthesized according to the instructions of the
GeneChip manufacturer (Affymetrix). The chips were analyzed
with the GCOS analysis system.
Whole-mount diaphragm in situ hybridiation
The E18.5 diaphragms were fixed in 4% PFA and dehydrated
in 100% methanol. After rehydration, the endogenous peroxidase
was inactivated with 6% H2O2. An antisense riboprobe for the
AChRa subunit was synthesized with a DIG-labeling kit (Roche).
Hybridization and color development were done by a standard
procedure [8].
Reverse transcription– polymerase chain reaction (RT-PCR)
Total RNA preparations were obtained from the synaptic and
extrasynapticregionsfromE18.5diaphragmsofwild-typeandmeltrin
b
2/2 mice. Primers: AChR a subunit, sense; CACTTTCCCTTC-
GATGAGCAGA, anti-sense; CCACAATGACCAGAAGGAA-
CAC, MuSK, sense; CAACATTCCCGTCAATAACGTC, anti-
sense; GTTTCACAATGTTGGGGTTGTC, ephrin-A5, sense;
ATGTTGACGCTGCTCTTTCTGGT, anti-sense; CGTTGTC-
TGGGATTGCAGAGGA.
Coimmunoprecipitation assay in vitro and in vivo
E13.5 spinal cords and DRG dissected and lysed with Triton-
X100 lysis buffer (25 mM Tris-HCl [pH 7.5], 100 mM NaCl,
2 mM EDTA, and 1% Triton-X100) containing protease inhibitor
cocktail (Nacalai, Japan) and incubated on ice for 1 h. The lysate
was centrifuged at 14,000 rpm for 10 minutes at 4C, and the
supernatant was precleared with protein G–conjugated Sepharose
beads (GE Healthcare) for 1 h at 4C, followed by incubation with
the anti-EphA4 antibody (Zymed) or control mouse IgG overnight
at 4C. Protein G-conjugated Sepharose beads were added and
washed several times after centrifugation, and then SDS-PAGE
was performed.
HEK293T cells or NIH3T3 cells were transfected with plasmids
by using the FuGene HD transfection reagent (Roche). The cells
were incubated for 36 h and then washed with ice-cold PBS and
lysed with Triton-X100 lysis buffer containing proteinase inhibitor
cocktail. Immunoprecipitation was performed as described above.
Endocytosis assay
EphA4-HA transformant cells were transfected with pBOS-meltrin
b WTorEQand incubated for 36 h, followed byreplacementofthe
growth medium with serum-free medium for 2 h. The cells were
washed once with Hanks balanced salt solution (HBSS, Invitrogen)
and incubated in HBSS at 12uCo r3 7 uC for 10 min. After this
treatment, 3 mg/ml human Fc or ephrin-A5-Fc (R&D systems,
nonclustered) proteins were added, and the mixture was incubated
for 15 min at 12uCo r3 7 uC respectively. The cells were washed
twice with HBSS and fixed with 4% PFA, followed by permeabiliza-
tion with 0.2% Triton-X 100/PBS solution. To label human Fc or
ephrin-A5-Fc proteins, goat anti-human Fc fragment antibodies
were added before the permeabilization for the cells incubated at
12uC and after the permeabilization for the cells incubated at 37uC.
Immunocytochemistry was performed. Single sections of confocal
images were captured on a Leica TCS SP5 confocal microscope.
Several fields were chosen randomly and the number of cells without
endosomes containing ephrin–Eph complexes was counted. The
experiment was performed in three 2-well glass culture slides on two
independent occasions. Student’s t-test was used for statistical
comparisons.
Supporting Information
Figure S1 (A–I) Meltrin b was not detected at the NMJ (BTX) at
E16.5 (A–C) but was clearly clustered at E18.5 (D–F: arrowheads).
The expression of Meltrin b was sustained in adult muscles (G–I:
arrowheads; also shown in Fig. 1). (J–R) Ephrin-A5 was not
detected at the NMJ at E16.5 (J–L) but was clearly clustered at
E18.5 (M–O: arrowheads; also shown in Fig. 3). Expression of
ephrin-A5 was sustained in adult muscles (P–R: arrowheads). (S)
Anti-Meltrin b antibody recognized Meltrin b proteins specifically
at the NMJ in E18.5 intercostal muscles. Meltrin b signal could be
hardly detected in meltrin b2/2 intercostal muscles. (T and U)
Negative controls for immunostaining: rabbit IgGs were used
instead of the anti-Meltrin b antibody (T and T’), and goat IgGs
were used instead of the anti-ephrin-A5 antibody (U and U’).
Found at: doi:10.1371/journal.pone.0003322.s001 (2.69 MB TIF)
Figure S2 (A and B) NIH3T3 celles were transfected with only
Meltrin b, cultured for 24 hours and immunocytochemistry was
performed with anti-Meltrin b antibody. Most of the Meltrin b
proteins were localized in cytoplasmic region as described
previoulsly. Bar: 10 mm. (C–E) NIH3T3 cells were transfected
with EphA4 and Meltrin b and cultured for 24 hours. The cells
were fixed, and Meltrin b and EphA4 were detected with anti-
Meltrin b antibody and ephrin-A5-Fc respectively. Ephrin-A5-Fc-
bound EphA4 proteins were localized on the plasma membrane (C
and E). Meltrin b was also detected on the plasma membrane (D
and E), although most Meltrin b proteins were localized in the
endoplasmic reticulum and the Golgi apparatus. (C’–E’) Magni-
fications of the square in C are shown. Meltrin b colocalized with
EphA4 (arrowheads). Upper bar: 10 mm, lower bar: 5 mm.
Found at: doi:10.1371/journal.pone.0003322.s002 (0.68 MB TIF)
Table S1 The expression profiles in the synaptic and extra-
synaptic regions in wild-type and meltrin b2/2 diaphragms were
compared by microarray analysis. All expressed genes were
divided into 3 groups: genes expressed more highly in synaptic
regions than in extrasynaptic regions of wild-type muscle; genes
expressed in synaptic regions more highly in wild-type than in
meltrin b2/2 muscle; and genes whose expression pattern was
different between wild-type and meltrin b2/2 muscles, including
genes expressed differentially in the synaptic and extrasynaptic
regions only in wild-type or meltrin b2/2 muscles. Genes that
satisfied the criteria of all 3 categories (represented by the light
pink region of overlap in Fig. 2D) are listed in this table.
Found at: doi:10.1371/journal.pone.0003322.s003 (0.97 MB TIF)
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